Quantcast
Last updated on April 21, 2014 at 8:55 EDT

Latest birth defects Stories

2011-04-19 14:29:26

New research in the FASEB Journal details the first evidence that breakdown products of thalidomide produce the specific, toxic effects of thalidomide in embryos Thalidomide may have been withdrawn in the early 1960s for use by pregnant women, but its dramatic effects remain memorable half a century later. Now, researchers have taken a major step toward understanding exactly how thalidomide causes the birth defects. This is important as thalidomide is still used to treat diseases like...

2011-04-15 00:00:30

Anticonvulsant medications such as Depakote are being found to possibly cause birth defects according to recent studies. Victims of these anticonvulsant birth defects may need financial help to provide potential life-long medical care for children born with such conditions as spina bifida, heart malformations, or physical cleft injuries. More information about this can be found at http://www.consumerjusticefoundation.com. (Vocus/PRWEB) April 14, 2011 The Consumer Justice Foundation (CJF)...

2011-04-12 00:00:30

Dilantin is one of the most widely prescribed anticonvulsant drugs on the U.S. market, primarily prescribed to individuals suffering from epilepsy. With the newly found potential connection between Dilantin use during pregnancy and the development of major birth defects, birth defect victims and their families are consulting Dilantin attorneys using http://www.dilantinbirthinjury.com regarding the benefits of filing a Dilantin lawsuit. The Consumer Justice Foundation is committed to helping...

2011-04-12 00:00:30

Topamax birth defect claims are being investigated across the country as parents may be unknowingly exposing infants to the anticonvulsant drug in utero, possibly increasing the risk of major birth defects. Topamax is an anticonvulsant medication manufactured by Johnson & Johnson and approved by the FDA in 1996 to treat individuals suffering from epilepsy and migraine headaches. The Consumer Justice Foundation has developed http://www.topamaxbirthinjury.com to help parents that have...

2011-03-31 00:00:28

As the FDA changes the pregnancy category of migraine drug Topamax to a class D drug, worry over the lack of drug testing for birth defects increases. The Wall Street Journal reports on a history of birth defects related to medications and pregnancy. Topamax Birth Injury Resources provides information and legal resources for families seeking compensation for a birth defect allegedly caused by Topamax. (PRWEB) March 30, 2011 On March 29, 2011 the Wall Street Journal covered the growing...

2011-03-30 00:00:28

The Senators Firm announced today that it is offering free confidential case reviews to people who took Topamax during pregnancy and suffered Topamax induced cleft lip, cleft palate, and oral cleft birth defects. Victims of Topamax birth defects may be eligible to file a Topamax lawsuit. Newport Beach, CA (PRWEB) March 28, 2011 The Senators (Ret.) Firm, LLP, announced today that it is continuing to investigate a number of reported cases of birth defects in children born to mothers who...

a8bd2cf6daa53f1153d0406b47a7ccd91
2011-03-29 05:55:00

A new report released Monday by the Natural Resources Defense Council (NRDC) documents 42 "disease clusters" in 13 states, each of which includes incidences of numerous types of cancer, birth defects or other chronic diseases. The study, conducted by the NRDC and the National Disease Clusters Alliance, incorporated research by governments and peer-reviewed academic studies.  The authors are calling for renewed federal support to help confirm these clusters, and to determine their...

2011-03-26 00:00:29

Topamax Birth Injury Resources (TBIR) is an online resource center dedicated to providing accurate and up-to-date information about the possible birth defects related to the use of the epilepsy drug Topamax. TBIR provides a means for families seeking legal council to connect with reputable Topamax lawyers via a free, no-obligation claim review form. (PRWEB) March 25, 2011 In March of 2011, the FDA issued a change in the pregnancy category for the anti-epileptic drug Topamax, revising its...

2011-03-18 00:00:28

The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March 19 Philadelphia, PA (Vocus/PRWEB) March 16, 2011 An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects. About one in every 33 babies born each year in the United States has some type of major birth defect. Birth defects are also the leading cause of infant death. The...

2011-03-16 11:00:00

PHILADELPHIA, March 16, 2011 /PRNewswire-USNewswire/ -- An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects. About one in every 33 babies born each year in the United States has some type of major birth defect. Birth defects are also the leading cause of infant death. The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March...